AAAAAA

   
Results: 1-24 |
Results: 24
SEROLOGICAL PREVALENCE OF HYPODERMA SPECIES IN CATTLE IN GREAT-BRITAIN (1995 96) AND THE RELATIVE VALUE OF SEROLOGICAL SURVEILLANCE OVER CLINICAL OBSERVATION/
Authors: WEBSTER KA DAWSON C FLOWERS M RICHARDS MS
Citation: Ka. Webster et al., SEROLOGICAL PREVALENCE OF HYPODERMA SPECIES IN CATTLE IN GREAT-BRITAIN (1995 96) AND THE RELATIVE VALUE OF SEROLOGICAL SURVEILLANCE OVER CLINICAL OBSERVATION/, Veterinary record, 141(11), 1997, pp. 261-263
LYSOPHOSPHATIDYLCHOLINE STIMULATES ACTIVATOR PROTEIN-1 AND THE C-JUN N-TERMINAL KINASE-ACTIVITY
Authors: FANG XJ GIBSON S FLOWERS M FURUI T BAST RC MILLS GB
Citation: Xj. Fang et al., LYSOPHOSPHATIDYLCHOLINE STIMULATES ACTIVATOR PROTEIN-1 AND THE C-JUN N-TERMINAL KINASE-ACTIVITY, The Journal of biological chemistry, 272(21), 1997, pp. 13683-13689
ALLOGENEIC PERIPHERAL-BLOOD STEM-CELL TRANSPLANTATION MAY BE ASSOCIATED WITH A HIGH-RISK OF CHRONIC GRAFT-VERSUS-HOST DISEASE
Authors: STOREK J GOOLEY T SIADAK M BENSINGER WI MALONEY DG CHAUNCEY TR FLOWERS M SULLIVAN KM WITHERSPOON RP ROWLEY SD HANSEN JA STORB R APPELBAUM FR
Citation: J. Storek et al., ALLOGENEIC PERIPHERAL-BLOOD STEM-CELL TRANSPLANTATION MAY BE ASSOCIATED WITH A HIGH-RISK OF CHRONIC GRAFT-VERSUS-HOST DISEASE, Blood, 90(12), 1997, pp. 4705-4709
UNRELATED DONOR LEUKOCYTE INFUSIONS (U-DLI) TO TREAT RELAPSE OR EBV-LYMPHOPROLIFERATIVE DISEASE (EBV-LPD) AFTER UNRELATED DONOR BONE-MARROWTRANSPLANTATION (BMT)
Authors: PORTER D COLLINS R MICK R KERNAN N GIRALT S FLOWERS M CASPER J DROBYSKI W LEAHEY A PARKER P BATES B KING R ANTIN J
Citation: D. Porter et al., UNRELATED DONOR LEUKOCYTE INFUSIONS (U-DLI) TO TREAT RELAPSE OR EBV-LYMPHOPROLIFERATIVE DISEASE (EBV-LPD) AFTER UNRELATED DONOR BONE-MARROWTRANSPLANTATION (BMT), Blood, 90(10), 1997, pp. 2622-2622
MARROW TRANSPLANTATION FOR CHRONIC MYELOID-LEUKEMIA - THE INFLUENCE OF PLASMA BUSULFAN LEVELS ON THE OUTCOME OF TRANSPLANTATION
Authors: SLATTERY JT CLIFT RA BUCKNER CD RADICH J STORER B BENSINGER WI SOLL E ANASETTI C BOWDEN R BRYANT E CHAUNCEY T DEEG HJ DONEY KC FLOWERS M GOOLEY T HANSEN JA MARTIN PJ MCDONALD GB NASH R PETERSDORF EW SANDERS JE SCHOCH G STEWART P STORB R SULLIVAN KM THOMAS ED WITHERSPOON RP APPELBAUM FR
Citation: Jt. Slattery et al., MARROW TRANSPLANTATION FOR CHRONIC MYELOID-LEUKEMIA - THE INFLUENCE OF PLASMA BUSULFAN LEVELS ON THE OUTCOME OF TRANSPLANTATION, Blood, 89(8), 1997, pp. 3055-3060
CYCLOSPORINE OR CYCLOSPORINE PLUS METHYLPREDNISOLONE FOR PROPHYLAXIS OF GRAFT-VERSUS-HOST DISEASE - A PROSPECTIVE, RANDOMIZED TRIAL
Authors: DEEG HJ LIN DY LEISENRING W BOECKH M ANASETTI C APPELBAUM FR CHAUNCEY TR DONEY K FLOWERS M MARTIN P NASH R SCHOCH G SULLIVAN KM WITHERSPOON RP STORB R
Citation: Hj. Deeg et al., CYCLOSPORINE OR CYCLOSPORINE PLUS METHYLPREDNISOLONE FOR PROPHYLAXIS OF GRAFT-VERSUS-HOST DISEASE - A PROSPECTIVE, RANDOMIZED TRIAL, Blood, 89(10), 1997, pp. 3880-3887
ALLOGENEIC MARROW TRANSPLANTATION FOR MYELODYSPLASTIC SYNDROME WITH ADVANCED DISEASE MORPHOLOGY - A PHASE-II STUDY OF BUSULFAN, CYCLOPHOSPHAMIDE, AND TOTAL-BODY IRRADIATION AND ANALYSIS OF PROGNOSTIC FACTORS
Authors: ANDERSON JE APPELBAUM FR SCHOCH G GOOLEY T ANASETTI C BENSINGER WI BRYANT E BUCKNER CD CHAUNCEY T CLIFT RA DEEG HJ DONEY K FLOWERS M HANSEN JA MARTIN PJ MATTHEWS DC NASH RA SANDERS JE SHULMAN H SULLIVAN KM WITHERSPOON RP STORB R
Citation: Je. Anderson et al., ALLOGENEIC MARROW TRANSPLANTATION FOR MYELODYSPLASTIC SYNDROME WITH ADVANCED DISEASE MORPHOLOGY - A PHASE-II STUDY OF BUSULFAN, CYCLOPHOSPHAMIDE, AND TOTAL-BODY IRRADIATION AND ANALYSIS OF PROGNOSTIC FACTORS, Journal of clinical oncology, 14(1), 1996, pp. 220-226
INCREASED RISK OF LATE CMV INFECTION AND DISEASE IN ALLOGENEIC MARROWTRANSPLANT RECIPIENTS AFTER GANCICLOVIR PROPHYLAXIS IS DUE TO A LACK OF CMV-SPECIFIC T-CELL RESPONSES
Authors: BOECKH M RIDDELL SR CUNNINGHAM T MYERSON D FLOWERS M BOWDEN RA
Citation: M. Boeckh et al., INCREASED RISK OF LATE CMV INFECTION AND DISEASE IN ALLOGENEIC MARROWTRANSPLANT RECIPIENTS AFTER GANCICLOVIR PROPHYLAXIS IS DUE TO A LACK OF CMV-SPECIFIC T-CELL RESPONSES, Blood, 88(10), 1996, pp. 1195-1195
LONG-TERM OUTCOME AND QUALITY-OF-LIFE AFTER MARROW TRANSPLANTATION FOR SEVERE APLASTIC-ANEMIA
Authors: DEEQ HJ LEISENRING W NIMS J FLOWERS M WITHERSPOON RP STORB R SULLIVAN KM
Citation: Hj. Deeq et al., LONG-TERM OUTCOME AND QUALITY-OF-LIFE AFTER MARROW TRANSPLANTATION FOR SEVERE APLASTIC-ANEMIA, Blood, 88(10), 1996, pp. 2560-2560
ALLOGENEIC MARROW TRANSPLANTATION FOR REFRACTORY-ANEMIA - A COMPARISON OF 2 PREPARATIVE REGIMENS AND ANALYSIS OF PROGNOSTIC FACTORS
Authors: ANDERSON JE APPELBAUM FR SCHOCH G GOOLEY T ANASETTI C BENSINGER WI BRYANT E BUCKNER CD CHAUNCEY TR CLIFT RA DONEY K FLOWERS M HANSEN JA MARTIN PJ MATTHEWS DC SANDERS JE SHULMAN H SULLIVAN KM WITHERSPOON RP STORB R
Citation: Je. Anderson et al., ALLOGENEIC MARROW TRANSPLANTATION FOR REFRACTORY-ANEMIA - A COMPARISON OF 2 PREPARATIVE REGIMENS AND ANALYSIS OF PROGNOSTIC FACTORS, Blood, 87(1), 1996, pp. 51-58
PUVA AS ADJUVANT PRIMARY OR SALVAGE TREATMENT FOR CHRONIC GRAFT-VERSUS-HOST DISEASE (GVHD)
Authors: THOMPSON D SULLIVAN K SEIDEL K ERICKSON K FLOWERS M SIADAK M APPELBAUM F OLERUD J STORB R
Citation: D. Thompson et al., PUVA AS ADJUVANT PRIMARY OR SALVAGE TREATMENT FOR CHRONIC GRAFT-VERSUS-HOST DISEASE (GVHD), Journal of investigative dermatology, 104(4), 1995, pp. 659-659
DETERMINANTS OF LATE INFECTION FOLLOWING MARROW TRANSPLANTATION (MT) FOR APLASTIC-ANEMIA (AA) AND MYELODYSPLASTIC SYNDROME (MDS)
Authors: SULLIVAN KM NIMS J LEISENRING W FLOWERS M BOWDEN R ANASETTI C DEEG HJ ANDERSON J APPELBAUM FR STORB R
Citation: Km. Sullivan et al., DETERMINANTS OF LATE INFECTION FOLLOWING MARROW TRANSPLANTATION (MT) FOR APLASTIC-ANEMIA (AA) AND MYELODYSPLASTIC SYNDROME (MDS), Blood, 86(10), 1995, pp. 841-841
PUVA AS ADJUVANT PRIMARY OR SALVAGE TREATMENT FOR CHRONIC GRAFT-VERSUS-HOST DISEASE (GVHD)
Authors: THOMPSON D SULLIVAN K SEIDEL K ERICKSON K FLOWERS M SIADAK M APPELBAUM F OLERUD J STORB R
Citation: D. Thompson et al., PUVA AS ADJUVANT PRIMARY OR SALVAGE TREATMENT FOR CHRONIC GRAFT-VERSUS-HOST DISEASE (GVHD), Blood, 86(10), 1995, pp. 1581-1581
ALFA-2A-INTERFERON PRODUCES DURABLE COMPLETE CYTOGENETIC RESPONSES INPATIENTS WITH CYTOGENETIC RELAPSE OF CHRONIC MYELOGENOUS LEUKEMIA AFTER MARROW TRANSPLANTATION
Authors: HIGANO C CHIELENS D BRYANT E RASKIND W RADICH J FLOWERS M
Citation: C. Higano et al., ALFA-2A-INTERFERON PRODUCES DURABLE COMPLETE CYTOGENETIC RESPONSES INPATIENTS WITH CYTOGENETIC RELAPSE OF CHRONIC MYELOGENOUS LEUKEMIA AFTER MARROW TRANSPLANTATION, Blood, 86(10), 1995, pp. 2253-2253
RECIPIENT-SPECIFIC DONOR CYTOTOXIC T-LYMPHOCYTES ENHANCE ENGRAFTMENT OF UNRELATED, DLA NONIDENTICAL CANINE MARROW
Authors: SCHWARZINGER I RAFF RF FLOWERS M NIEDERWIESER D GRAHAM T SHULMAN H APPELBAUM FR SCHUENING F STORB R
Citation: I. Schwarzinger et al., RECIPIENT-SPECIFIC DONOR CYTOTOXIC T-LYMPHOCYTES ENHANCE ENGRAFTMENT OF UNRELATED, DLA NONIDENTICAL CANINE MARROW, Bone marrow transplantation, 13(3), 1994, pp. 303-309
PROSTAGLANDIN-E IN THE TREATMENT OF RECURRENT HEPATITIS-B INFECTION AFTER ORTHOTOPIC LIVER-TRANSPLANTATION
Authors: FLOWERS M SHERKER A SINCLAIR SB GREIG PD CAMERON R PHILLIPS MJ BLENDIS L CHUNG SW LEVY GA
Citation: M. Flowers et al., PROSTAGLANDIN-E IN THE TREATMENT OF RECURRENT HEPATITIS-B INFECTION AFTER ORTHOTOPIC LIVER-TRANSPLANTATION, Transplantation, 58(2), 1994, pp. 183-192
A TH1 CELL-LINE (3E9.I) FROM RESISTANT A J MICE INHIBITS INDUCTION OFMACROPHAGE PROCOAGULANT ACTIVITY IN-VITRO AND PROTECTS AGAINST MHV-3 MORTALITY IN-VIVO/
Authors: CHUNG S GORCZYNSKI R CRUZ B FINGEROTE R SKAMENE E PERLMAN S LEIBOWITZ J FUNG L FLOWERS M LEVY G
Citation: S. Chung et al., A TH1 CELL-LINE (3E9.I) FROM RESISTANT A J MICE INHIBITS INDUCTION OFMACROPHAGE PROCOAGULANT ACTIVITY IN-VITRO AND PROTECTS AGAINST MHV-3 MORTALITY IN-VIVO/, Immunology, 83(3), 1994, pp. 353-361
CYCLOPHOSPHAMIDE COMBINED WITH ANTITHYMOCYTE GLOBULIN IN PREPARATION FOR ALLOGENEIC MARROW TRANSPLANTS IN PATIENTS WITH APLASTIC-ANEMIA
Authors: STORB R ETZIONI R ANASETTI C APPELBAUM FR BUCKNER CD BENSINGER W BRYANT E CLIFT R DEEG HJ DONEY K FLOWERS M HANSEN J MARTIN P PEPE M SALE G SANDERS J SINGER J SULLIVAN KM THOMAS ED WITHERSPOON RP
Citation: R. Storb et al., CYCLOPHOSPHAMIDE COMBINED WITH ANTITHYMOCYTE GLOBULIN IN PREPARATION FOR ALLOGENEIC MARROW TRANSPLANTS IN PATIENTS WITH APLASTIC-ANEMIA, Blood, 84(3), 1994, pp. 941-949
NEGATIVE IMPACT OF PRIOR CENTRAL-NERVOUS-SYSTEM (CNS) IRRADIATION ON GROWTH AND NEUROPSYCHOLOGICAL FUNCTION (NPSF) AFTER TOTAL-BODY IRRADIATION (TBI) AND BONE-MARROW TRANSPLANT (BMT)
Authors: SANDERS J FLOWERS M SIADEK M MCGUIRE T
Citation: J. Sanders et al., NEGATIVE IMPACT OF PRIOR CENTRAL-NERVOUS-SYSTEM (CNS) IRRADIATION ON GROWTH AND NEUROPSYCHOLOGICAL FUNCTION (NPSF) AFTER TOTAL-BODY IRRADIATION (TBI) AND BONE-MARROW TRANSPLANT (BMT), Blood, 84(10), 1994, pp. 10000250-10000250
INJURIES SUSTAINED DURING FLIPPING - A NEW FAD ACTIVITY
Authors: GOEPP JG WALKER A FLOWERS M CALIMANO A SMITH D
Citation: Jg. Goepp et al., INJURIES SUSTAINED DURING FLIPPING - A NEW FAD ACTIVITY, Pediatric emergency care, 9(2), 1993, pp. 95-97
MARROW TRANSPLANTATION FOR FANCONI-ANEMIA WITH OR WITHOUT LEUKEMIC TRANSFORMATION
Authors: DEEG HJ FLOWERS M BRYANT E SANDERS J HANSEN J STORB R
Citation: Hj. Deeg et al., MARROW TRANSPLANTATION FOR FANCONI-ANEMIA WITH OR WITHOUT LEUKEMIC TRANSFORMATION, Experimental hematology, 21(5), 1993, pp. 724-724
ALPHA-INTERFERON (IFN) RESULTS IN HIGH COMPLETE CYTOGENETIC RESPONSE RATE IN PATIENTS WITH CYTOGENETIC-ONLY RELAPSE OF CHRONIC MYELOGENOUS LEUKEMIA (CML) AFTER MARROW TRANSPLANTATION (BMT)
Authors: HIGANO C RASKIND W FLOWERS M
Citation: C. Higano et al., ALPHA-INTERFERON (IFN) RESULTS IN HIGH COMPLETE CYTOGENETIC RESPONSE RATE IN PATIENTS WITH CYTOGENETIC-ONLY RELAPSE OF CHRONIC MYELOGENOUS LEUKEMIA (CML) AFTER MARROW TRANSPLANTATION (BMT), Blood, 82(10), 1993, pp. 10000169-10000169
COMPARISON OF CYCLOSPORINE (CSP), PREDNISONE (PRED) OR ALTERNATING-DAY CSP PRED IN PATIENTS WITH STANDARD AND HIGH-RISK CHRONIC GRAFT-VERSUS-HOST DISEASE (GVHD)/
Authors: SULLIVAN KM GOOLEY T NIMS J FLOWERS M LIN D ANASETTI C SANDERS J WITHERSPOON R APPELBAUM FR STORB R
Citation: Km. Sullivan et al., COMPARISON OF CYCLOSPORINE (CSP), PREDNISONE (PRED) OR ALTERNATING-DAY CSP PRED IN PATIENTS WITH STANDARD AND HIGH-RISK CHRONIC GRAFT-VERSUS-HOST DISEASE (GVHD)/, Blood, 82(10), 1993, pp. 10000215-10000215
BONE-MARROW TRANSPLANTATION (BMT) IN 32 PATIENTS (PTS) WITH FANCONIS ANEMIA (FA) AFTER CONDITIONING WITH CYCLOPHOSPHAMIDE (CY)
Authors: FLOWERS M ZANIS J STORB R PASQUINI R DEEG J RIBEIRO R SANDERS J BRYANT E SULLIVAN K APPELBAUM F
Citation: M. Flowers et al., BONE-MARROW TRANSPLANTATION (BMT) IN 32 PATIENTS (PTS) WITH FANCONIS ANEMIA (FA) AFTER CONDITIONING WITH CYCLOPHOSPHAMIDE (CY), Blood, 82(10), 1993, pp. 10000344-10000344
Risultati: 1-24 |